Ueda P - Search Results

1

Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Bladder and Renal Cancer: Scandinavian Cohort Study.

Ueda P, Svanström H, Hviid A, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Wintzell V, Melbye M, Pasternak B. Ueda P, et al. Diabetes Care. 2022 May 1;45(5):e93-e96. doi: 10.2337/dc21-1917. Diabetes Care. 2022. PMID: 35312767 Free PMC article. No abstract available.

2

Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults.

NCD Risk Factor Collaboration (NCD-RisC). NCD Risk Factor Collaboration (NCD-RisC). Lancet. 2017 Dec 16;390(10113):2627-2642. doi: 10.1016/S0140-6736(17)32129-3. Epub 2017 Oct 10. Lancet. 2017. PMID: 29029897 Free PMC article.

3

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.

Ueda P, Svanström H, Melbye M, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Pasternak B. Ueda P, et al. BMJ. 2018 Nov 14;363:k4365. doi: 10.1136/bmj.k4365. BMJ. 2018. PMID: 30429124 Free PMC article.

4

Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden.

Svanström H, Ueda P, Melbye M, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Pasternak B. Svanström H, et al. Among authors: ueda p. Lancet Diabetes Endocrinol. 2019 Feb;7(2):106-114. doi: 10.1016/S2213-8587(18)30320-6. Epub 2018 Dec 5. Lancet Diabetes Endocrinol. 2019. PMID: 30527909

5

Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries.

Ueda P, Pasternak B, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Melbye M, Svanström H. Ueda P, et al. Diabetes Care. 2019 Jun;42(6):e92-e94. doi: 10.2337/dc18-2532. Epub 2019 Apr 22. Diabetes Care. 2019. PMID: 31010872 No abstract available.

6

Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.

Pasternak B, Ueda P, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Wintzell V, Melbye M, Svanström H. Pasternak B, et al. Among authors: ueda p. BMJ. 2019 Aug 29;366:l4772. doi: 10.1136/bmj.l4772. BMJ. 2019. PMID: 31467044 Free PMC article.

7

Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study.

Pasternak B, Wintzell V, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Melbye M, Svanström H, Ueda P. Pasternak B, et al. Among authors: ueda p. Diabetes Care. 2020 Jun;43(6):1326-1335. doi: 10.2337/dc19-2088. Epub 2020 Apr 15. Diabetes Care. 2020. PMID: 32295809

8

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study.

Pasternak B, Wintzell V, Melbye M, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Svanström H, Ueda P. Pasternak B, et al. Among authors: ueda p. BMJ. 2020 Apr 29;369:m1186. doi: 10.1136/bmj.m1186. BMJ. 2020. PMID: 32349963 Free PMC article.

9

Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study.

Ueda P, Wintzell V, Melbye M, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Svanström H, Pasternak B. Ueda P, et al. Diabetologia. 2021 Oct;64(10):2204-2214. doi: 10.1007/s00125-021-05508-1. Epub 2021 Jul 13. Diabetologia. 2021. PMID: 34254177 Free PMC article.

10

The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort study.

Ueda P, Wintzell V, Dahlqwist E, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Melbye M, Hviid A, Svanström H, Pasternak B. Ueda P, et al. Diabetes Obes Metab. 2022 Mar;24(3):473-485. doi: 10.1111/dom.14598. Epub 2021 Nov 24. Diabetes Obes Metab. 2022. PMID: 34738703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters